References
1. Bai Y., Yao L., Wei T., Tian F., Jin D.Y., Chen L., et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020; 323 (14): 1406-7.
2. Li R., Pei S., Chen B., Song Y., Zhang T., Yang W., et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science. 2020; 368 (6490): 489-93.
3. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382 (18): 1708-20.
4. Perico L., Benigni A., Remuzzi G. Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockad. Nephron. 2020; 144 (5): 213-21.
5. Ronco C., Reis T., Husain-Syed F Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020; 8 (7): 738-42.
6. Arslan H., Musabak U., Soy E.H.A., Azap O.K., Sayin B., Akcay S., et al. Incidence and immunologic analysis of coronavirus disease (COVID-19) in hemodialysis patients: a single-center experience. Exp Clin Transplant. 2020; 18 (3): 275-83.
7. CorbettR.W., Blakey S., Nitsch D., Loucaidou M., McLeanA., Duncan N., et al. Epidemiology of COVID-19 in an Urban Dialysis Center. J Am Soc Nephrol. 2020; 31 (8): 1815-23.
8. Ma Y., Diao B., Lv X., Zhu J., Liang W., Liu L., et al. 2019 novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan China. medRxiv. 2020. DOI: https://doi.org/10.1101/2020.02.24.20027201
9. Li C., Yonglong M., Can T., Dongdong M., Sheng W., Haifeng L., et al. An Analysis on the clinical features of MHD patients with coronavirus disease 2019: a single center study. 2020. DOI: https://doi.org/10.21203/rs.3.rs-18043/v1
10. Alberici F., Delbarba E., Manenti C., Econimo L., Valerio F., Pola A., et al. Management of patients on dialysis and with kidney transplant during SARS-COV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep. 2020; 5 (5): 580-5.
11. Bonny V., Maillard A., Mousseaux C., Plagais L., Richier Q. COVID-19: Pathogenesis of a multi-faceted disease. Rev Med Interne. 2020; 41 (6): 375-89.
12. Interim guidelines "Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)". Version 8.1 (October 1, 2020). Moscow, 2020. (in Russian)
13. Ranieri V.M., Rubenfeld G.D., Thompson B.T., Ferguson N.D., Caldwell E., Fan E., et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307 (23): 2526-33.
14. Hemmelgarn B.R., Manns B.J., Quan H., Ghali W.A. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis. 2003; 42 (1): 125-32.
15. Zhang Y.; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020. China CDC Weekly. 2020; 2: 113-22.
16. Gagliardi I., Patella G., Michael A., Serra R., Provenzano M., An-dreucci M. COVID-19 and the kidney: from epidemiology to clinical practice. J Clin Med. 2020; 9 (8): 2506.
17. Cheng Y., Luo R., Wang K., Zhang M., Wang Z., Dong L., et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020; 97 (5): 829-38.
18. Wang L., Li X., Chen H., Yan S., Li D., Li Y., et al. Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. Am J Nephrol. 2020; 51 (5): 343-8.
19. Zhang J., Litvinova M., Wang W., Wang Y., Deng X., Chen X., et al. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. Lancet Infect Dis. 2020; 20 (7): 793-802.
20. Boraschi P COVID-19 Pulmonary involvement: is really an interstitial pneumonia? Acad Radiol. 2020; 27 (6): 900.
21. Henry B.M., Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020; 52 (6): 1193-4.
22. Wang R., Liao C., He H., Hu C., Wei Z., Hong Z., et al. COVID-19 in hemodialysis patients: a report of 5 cases. Am J Kidney Dis. 2020; 76 (1): 141-6.
23. Hande A., Ugur M., Ebru H.A.S., Ozlem K.A., Burak S., Sule A., et al. Incidence and immunologic analysis of coronavirus disease (COVID-19) in hemodialysis patients: a single-center experience. Exp Clin Transplant. 2020; 18 (3): 275-83.
24. Xiong F., Tang H., Liu L., Tu C., Tian J., Lei C., et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China. J Am Soc Nephrol. 2020; 31 (7): 1387-97.
25. Rombola G., Brunini F COVID-19 and dialysis: why we should be worried. J Nephrol. 2020; 33 (3): 401-3.
26. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 392 (18): 1708-20.
27. Grasselli G., Zangrillo A., Zanella A., Antonelli M., Cabrini L., Castelli A., et al. COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323 (16): 1574-81.
28. Yi Y., Lagniton P.N.P., Ye S., Li E., Xu R.H. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020; 16 (10): 1753-66.
29. Madjid M., Safavi-Naeini P, Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020; 5 (7): 831-40.
30. COVID-19 Registro ERA-EDTA. URL: https://www.era-edta.org/en/registry/ (date of access 3 August, 2020)
31. Alberici F., Delbarba E., Manenti C., Econimo L., Valerio F., Pola A., et al. Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep. 2020; 5 (5): 580-5.
32. Scarpioni R., Manini A., Valsania T., Amicis S.D., Albertazzi V., Melfa L., et al. COVID-19 and its impact on nephropathic patients: the experience at Ospedale «Guglielmo da Saliceto» in Piacenza. G Ital Nefrol. 2020; 37 (2): 1-5.
33. Ma Y., Diao B., Lv X., Zhu J., Liang W., Liu L., et al. 2019 novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan China. medRxiv. 2020. DOI: https://doi.org/10.1101/2020.02.24.20027201 (date of access June 17, 2020)
34. Goicoechea M., Luis Camara A.S., Macfas N., Morales A.M., Rojas A.G., Bascunana A., et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. 2020; 98 (1): 27-34.
35. Manganaro M., Baldovino S. First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy. J Nephrol. 2020; 33 (3): 393-5.
36. Singh A.K., Gupta R., Ghosh A., Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020; 14 (4): 303-10.
37. Scheen A.J. Obesity and risk of severe COVID-19. Rev Med Suisse. 2020; 16 (695): 1115-9.
38. Li X., Wang L., Yan S., Yang F., Xiang L., Zhu J., et al. Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis. 2020; 94: 128-32.
39. Zhou F., Yu T., Du R., Fan G., Liu Y., Liuet Z., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 (10 229): 1054-62.